216 related articles for article (PubMed ID: 17977901)
21. Gender-selective toxicity of thimerosal.
Branch DR
Exp Toxicol Pathol; 2009 Mar; 61(2):133-6. PubMed ID: 18771903
[TBL] [Abstract][Full Text] [Related]
22. Immunosuppressive and autoimmune effects of thimerosal in mice.
Havarinasab S; Häggqvist B; Björn E; Pollard KM; Hultman P
Toxicol Appl Pharmacol; 2005 Apr; 204(2):109-21. PubMed ID: 15808517
[TBL] [Abstract][Full Text] [Related]
23. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.
Parker SK; Schwartz B; Todd J; Pickering LK
Pediatrics; 2004 Sep; 114(3):793-804. PubMed ID: 15342856
[TBL] [Abstract][Full Text] [Related]
24. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal.
Burbacher TM; Shen DD; Liberato N; Grant KS; Cernichiari E; Clarkson T
Environ Health Perspect; 2005 Aug; 113(8):1015-21. PubMed ID: 16079072
[TBL] [Abstract][Full Text] [Related]
25. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders.
Geier DA; Geier MR
Pediatr Rehabil; 2003; 6(2):97-102. PubMed ID: 14534046
[TBL] [Abstract][Full Text] [Related]
26. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
Heron J; Golding J;
Pediatrics; 2004 Sep; 114(3):577-83. PubMed ID: 15342824
[TBL] [Abstract][Full Text] [Related]
27. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
28. A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders.
Geier DA; Geier MR
J Toxicol Environ Health A; 2007 May; 70(10):837-51. PubMed ID: 17454560
[TBL] [Abstract][Full Text] [Related]
29. Toxicology and Carcinogenesis Studies of Mercuric Chloride (CAS No. 7487-94-7) in F344 Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Feb; 408():1-260. PubMed ID: 12621522
[TBL] [Abstract][Full Text] [Related]
30. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.
Geier DA; Geier MR
Med Sci Monit; 2004 Mar; 10(3):PI33-9. PubMed ID: 14976450
[TBL] [Abstract][Full Text] [Related]
31. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
Fombonne E; Zakarian R; Bennett A; Meng L; McLean-Heywood D
Pediatrics; 2006 Jul; 118(1):e139-50. PubMed ID: 16818529
[TBL] [Abstract][Full Text] [Related]
32. An assessment of thimerosal use in childhood vaccines.
Ball LK; Ball R; Pratt RD
Pediatrics; 2001 May; 107(5):1147-54. PubMed ID: 11331700
[TBL] [Abstract][Full Text] [Related]
33. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
34. [Mercury in vaccines].
Hessel L
Bull Acad Natl Med; 2003; 187(8):1501-10. PubMed ID: 15146581
[TBL] [Abstract][Full Text] [Related]
35. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis.
Geier D; Geier MR
Int J Toxicol; 2004; 23(6):369-76. PubMed ID: 15764492
[TBL] [Abstract][Full Text] [Related]
36. A systematic study of the disposition and metabolism of mercury species in mice after exposure to low levels of thimerosal (ethylmercury).
Carneiro MF; Oliveira Souza JM; Grotto D; Batista BL; de Oliveira Souza VC; Barbosa F
Environ Res; 2014 Oct; 134():218-27. PubMed ID: 25173055
[TBL] [Abstract][Full Text] [Related]
37. Continuing increases in autism reported to California's developmental services system: mercury in retrograde.
Schechter R; Grether JK
Arch Gen Psychiatry; 2008 Jan; 65(1):19-24. PubMed ID: 18180424
[TBL] [Abstract][Full Text] [Related]
38. Neonatal administration of a vaccine preservative, thimerosal, produces lasting impairment of nociception and apparent activation of opioid system in rats.
Olczak M; Duszczyk M; Mierzejewski P; Majewska MD
Brain Res; 2009 Dec; 1301():143-51. PubMed ID: 19747466
[TBL] [Abstract][Full Text] [Related]
39. A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States.
Geier DA; Geier MR
Neuro Endocrinol Lett; 2006 Aug; 27(4):401-13. PubMed ID: 16807526
[TBL] [Abstract][Full Text] [Related]
40. NTP Toxicology and Carcinogenesis Studies of Triethanolamine (CAS No. 102-71-6) in F344 Rats and B6C3F1 Mice (Dermal Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Nov; 449():1-298. PubMed ID: 12594526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
